HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,828 | +10.7% | 100,200 | +4.7% | 0.01% | +12.5% |
| Q2 2023 | $3,458 | -15.9% | 95,713 | -11.1% | 0.01% | -20.0% |
| Q1 2023 | $4,111 | -34.3% | 107,646 | -2.1% | 0.01% | -37.5% |
| Q4 2022 | $6,261 | -99.8% | 109,923 | +19.5% | 0.02% | +60.0% |
| Q3 2022 | $3,636,000 | -2.2% | 92,008 | +8.9% | 0.01% | 0.0% |
| Q2 2022 | $3,717,000 | +19.4% | 84,464 | +11.1% | 0.01% | +66.7% |
| Q1 2022 | $3,113,000 | +10.2% | 76,036 | +8.1% | 0.01% | 0.0% |
| Q4 2021 | $2,826,000 | +4.6% | 70,307 | +6.6% | 0.01% | 0.0% |
| Q3 2021 | $2,703,000 | +15.1% | 65,928 | +27.5% | 0.01% | +20.0% |
| Q2 2021 | $2,348,000 | +14.4% | 51,711 | +4.9% | 0.01% | 0.0% |
| Q1 2021 | $2,052,000 | -10.0% | 49,284 | -7.7% | 0.01% | +25.0% |
| Q4 2020 | $2,280,000 | +895.6% | 53,422 | +511.4% | 0.00% | – |
| Q3 2020 | $229,000 | -1.7% | 8,737 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $233,000 | +22.6% | 8,737 | -16.7% | 0.00% | 0.0% |
| Q1 2020 | $190,000 | +2.7% | 10,489 | 0.0% | 0.00% | – |
| Q4 2019 | $185,000 | -29.4% | 10,489 | -31.4% | 0.00% | -100.0% |
| Q2 2019 | $262,000 | -8.1% | 15,298 | -13.9% | 0.00% | 0.0% |
| Q1 2019 | $285,000 | +41.1% | 17,763 | +24.3% | 0.00% | 0.0% |
| Q4 2018 | $202,000 | -22.3% | 14,291 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $260,000 | +7.9% | 14,291 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $241,000 | -14.2% | 14,291 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $281,000 | -2.8% | 14,291 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $289,000 | +16.5% | 14,291 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $248,000 | +95.3% | 14,291 | +44.1% | 0.00% | – |
| Q2 2017 | $127,000 | -0.8% | 9,920 | 0.0% | 0.00% | – |
| Q1 2017 | $128,000 | +30.6% | 9,920 | 0.0% | 0.00% | – |
| Q4 2016 | $98,000 | -59.2% | 9,920 | -50.0% | 0.00% | – |
| Q3 2016 | $240,000 | +182.4% | 19,840 | +100.0% | 0.00% | – |
| Q2 2016 | $85,000 | -9.6% | 9,920 | 0.0% | 0.00% | – |
| Q1 2016 | $94,000 | -45.0% | 9,920 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $171,000 | +28.6% | 9,920 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $133,000 | -40.4% | 9,920 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $223,000 | +58.2% | 9,920 | 0.0% | 0.00% | – |
| Q1 2015 | $141,000 | +166.0% | 9,920 | +79.9% | 0.00% | – |
| Q4 2014 | $53,000 | +6.0% | 5,513 | 0.0% | 0.00% | – |
| Q3 2014 | $50,000 | -7.4% | 5,513 | 0.0% | 0.00% | – |
| Q2 2014 | $54,000 | -22.9% | 5,513 | 0.0% | 0.00% | – |
| Q1 2014 | $70,000 | -15.7% | 5,513 | 0.0% | 0.00% | – |
| Q4 2013 | $83,000 | – | 5,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
| BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
| Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
| SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
| QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
| JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
| EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
| Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |